NDC Product Labeler Ascendis Pharma Endocrinology, Inc.

Ascendis Pharma Endocrinology, Inc. labeler's code is 73362. The labeler has 12 products that have an assigned National Drug Code.

NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Product Type	Status
73362-003	Skytrofa	Lonapegsomatropin-tcgd	Injection, Powder, Lyophilized, For Solution	Subcutaneous	Human Prescription Drug	ACTIVE
73362-004	Skytrofa	Lonapegsomatropin-tcgd	Injection, Powder, Lyophilized, For Solution	Subcutaneous	Human Prescription Drug	ACTIVE
73362-005	Skytrofa	Lonapegsomatropin-tcgd	Injection, Powder, Lyophilized, For Solution	Subcutaneous	Human Prescription Drug	ACTIVE
73362-006	Skytrofa	Lonapegsomatropin-tcgd	Injection, Powder, Lyophilized, For Solution	Subcutaneous	Human Prescription Drug	ACTIVE
73362-007	Skytrofa	Lonapegsomatropin-tcgd	Injection, Powder, Lyophilized, For Solution	Subcutaneous	Human Prescription Drug	ACTIVE
73362-008	Skytrofa	Lonapegsomatropin-tcgd	Injection, Powder, Lyophilized, For Solution	Subcutaneous	Human Prescription Drug	ACTIVE
73362-009	Skytrofa	Lonapegsomatropin-tcgd	Injection, Powder, Lyophilized, For Solution	Subcutaneous	Human Prescription Drug	ACTIVE
73362-010	Skytrofa	Lonapegsomatropin-tcgd	Injection, Powder, Lyophilized, For Solution	Subcutaneous	Human Prescription Drug	ACTIVE
73362-011	Skytrofa	Lonapegsomatropin-tcgd	Injection, Powder, Lyophilized, For Solution	Subcutaneous	Human Prescription Drug	ACTIVE
73362-100	Yorvipath	Palopegteriparatide	Injection, Solution	Subcutaneous	Human Prescription Drug	ACTIVE
73362-101	Yorvipath	Palopegteriparatide	Injection, Solution	Subcutaneous	Human Prescription Drug	ACTIVE
73362-102	Yorvipath	Palopegteriparatide	Injection, Solution	Subcutaneous	Human Prescription Drug	ACTIVE